Cardiovascular risk in newly diagnosed type 2 diabetes patients in India

被引:18
|
作者
Unnikrishnan, A. G. [1 ]
Sahay, R. K. [2 ]
Phadke, Uday [3 ]
Sharma, S. K. [4 ]
Shah, Parag [5 ]
Shukla, Rishi [6 ]
Viswanathan, Vijay [7 ]
Wangnoo, S. K. [8 ]
Singhal, Santosh [9 ]
John, Mathew [10 ]
Kumar, Ajay [11 ]
Dharmalingam, Mala [12 ]
Jain, Subodh [13 ]
Shaikh, Shehla [14 ]
Verberk, Willem J. [15 ]
机构
[1] Chellaram Diabet Inst, Pune, Maharashtra, India
[2] Osmania Gen Hosp, Osmania Med Coll, Dept Endocrinol, Hyderabad, India
[3] Sahyadri Hosp, Pune, Maharashtra, India
[4] Galaxy Special Ctr, Jaipur, Rajasthan, India
[5] Gujarat Endocrine Ctr, Ahmadabad, Gujarat, India
[6] Dr Rishi Shukla Ctr Diabet & Endocrine Dis, Kanpur, Uttar Pradesh, India
[7] MV Hosp Diabetes, Chennai, Tamil Nadu, India
[8] Indraprashth Apollo Hosp, New Delhi, India
[9] Sparsh Hlth Care & CHS Apple Hosp, Gwalior, Madhya Pradesh, India
[10] Providence Endocrine & Diabet Specialty Ctr, Trivandrum, Kerala, India
[11] Diabet Care & Res Ctr, Patna, Bihar, India
[12] Bangalore Endocrinol & Ctr, Bangalore, Karnataka, India
[13] Diabet Care Ctr, Prayagraj, Uttar Pradesh, India
[14] KGN Diabet & Endocrinol Ctr, Mumbai, Maharashtra, India
[15] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
来源
PLOS ONE | 2022年 / 17卷 / 03期
关键词
INSULIN-RESISTANCE; VASCULAR-DISEASE; METAANALYSIS; NICOTINE; MELLITUS; CHOLESTEROL; MECHANISMS; SMOKING; GOALS;
D O I
10.1371/journal.pone.0263619
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. Methods A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. Results Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as "High risk" and 3,073 (60.5%) were classified as "Very high risk" based on LAI criteria. On average, patients had 1.7 +/- 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 +/- 12.3%, (12.2 +/- 10.1 vs. 17.1 +/- 13.5 [p<0.001] for females and males, respectively). Conclusions Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
    R. N. Guzder
    W. Gatling
    M. A. Mullee
    C. D. Byrne
    Diabetologia, 2006, 49 : 49 - 55
  • [22] Hypercortisolism in Newly Diagnosed Type 2 Diabetes: A Prospective Study of 384 Newly Diagnosed Patients
    Steffensen, Charlotte
    Dekkers, Olaf M.
    Lyhne, Johanne
    Pedersen, Bodil G.
    Rasmussen, Finn
    Rungby, Jorgen
    Poulsen, Per Logstrup
    Jorgensen, Jens Otto Lunde
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 62 - 68
  • [23] Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study
    Kristensen, Frederik Pagh Bredahl
    Christensen, Diana Hedevang
    Mortensen, Martin Bodtker
    Maeng, Michael
    Kahlert, Johnny
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [24] Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study
    Frederik Pagh Bredahl Kristensen
    Diana Hedevang Christensen
    Martin Bødtker Mortensen
    Michael Maeng
    Johnny Kahlert
    Henrik Toft Sørensen
    Reimar Wernich Thomsen
    Cardiovascular Diabetology, 22
  • [25] Weight history of patients with newly diagnosed Type 2 diabetes
    Olivarius, N. de Fine
    Richelsen, B.
    Siersma, V.
    Andreasen, A. H.
    Beck-Nielsen, H.
    DIABETIC MEDICINE, 2008, 25 (08) : 933 - 941
  • [26] OF NEWLY DIAGNOSED DIABETES MELLITUS TYPE 2 IN HYPERTENSIVE PATIENTS
    Rodilla Sala, E.
    Escriva, M.
    Garcia, J.
    Costa, J. A.
    Pascual, J. M.
    Rodilla Sala, E.
    JOURNAL OF HYPERTENSION, 2015, 33 : E173 - E173
  • [27] Risk scores overestimated risk for CVD in newly diagnosed type 2 diabetes
    Tanner, Michael
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (10) : JC59 - JC59
  • [28] Risk of Newly Diagnosed Type 2 Diabetes Is Reduced in Users of Alendronate
    Peter Vestergaard
    Calcified Tissue International, 2011, 89 : 265 - 270
  • [29] Risk of Newly Diagnosed Type 2 Diabetes Is Reduced in Users of Alendronate
    Vestergaard, Peter
    CALCIFIED TISSUE INTERNATIONAL, 2011, 89 (04) : 265 - 270
  • [30] CONTEMPORARY TREATMENT PATTERNS FOR NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS IN PATIENTS WITH AND WITHOUT CARDIOVASCULAR DISEASE
    Koutroumpakis, Efstratios
    Hamden, Randa
    Deswal, Anita
    Tung, Poyee
    Nambi, Vijay
    Krause, Trudy
    Aguilar, David
    Aguilar, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2041 - 2041